
Auteur B. LE DARE
|
Documents disponibles écrits par cet auteur (4)

B. LE DARE ; A. DEGREMONT ; C. COUTY ; A. BAERT ; R. BOUVET ; I. MOREL ; T. GICQUEL | 2021
Dans Preventive Medicine Reports (Vol.23, September 2021) Article : PériodiqueThe primary objective of the present study was to evaluate the frequency of positive tests for alcohol and drugs during roadside testing or after road accidents among drivers in the Brittany region of France. The study's secondary objective was [...]
R. PELLETIER ; B. LE DARE ; D. LE BOUEDEC ; A. BOURDAIS ; P. J. FERRON ; I. MOREL ; F. H. POREE ; T. GICQUEL | 2024
Dans Archives of Toxicology (Vol.98, n°1, January 2024) Article : PériodiqueEutylone is a cathinone-derived synthetic amphetamine scheduled by the World Health Organization and European Monitoring Centre for Drugs and Drug Addiction since 2022 due to its growing consumption. We report here an eutylone intoxication invol[...]
B. CORSO ; A. BACLE ; E. DEMAY ; M. MERCEROLLE ; R. PELLETIER ; T. GICQUEL ; B. LE DARE | 2023
Dans Annales Pharmaceutiques Françaises (Vol.81, n°4, Juin 2023) Article : PériodiqueENGLISH: Objectives: To date, very few cannabis-based specialities are authorised on the French market despite a growing demand from patients and health professionals. The objective of this study is to review the tolerance profile and the Frenc[...]
R. GONCALVES ; R. PELLETIER ; A. COUETTE ; T. GICQUEL ; B. LE DARE | 2022
Dans Toxicologie Analytique et Clinique (Vol.34, n°1 Suppl., Janvier 2022) Article : PériodiqueHigh-resolution mass spectrometry (HRMS) is now the method of choice in several toxicology contexts. This paper reviews HRMS approaches for research and application in various toxicology fields, focusing on drugs of abuse in clinical and forensi[...]